Literature DB >> 29905080

Conformation-Dependent Interactions Between HIV-1 Envelope Glycoproteins and Broadly Neutralizing Antibodies.

Juliana Flemming1, Lisa Wiesen1, Alon Herschhorn1.   

Abstract

HIV type 1 (HIV-1) envelope glycoproteins (Env) mediate virus entry and are the target of neutralizing antibodies. Binding of the metastable HIV-1 Env trimer to the CD4 receptor triggers structural rearrangements that mediate Env conformational transitions from a closed conformation to a more open state through an intermediate step. Recent studies have revealed new insights on the dynamics, regulation, and molecular mechanisms of Env transitions along the entry pathway. In this study, we provide an overview of the current knowledge on Env conformational dynamics and the relationship between Env conformational states and neutralization selectivity of the broadly neutralizing antibodies that develop in 10%-20% of infected individuals and may provide guidance for the development of an effective HIV-1 vaccine.

Entities:  

Keywords:  HIV-1 entry; HIV-1 envelope glycoproteins; broadly neutralizing antibodies; conformational transitions

Mesh:

Substances:

Year:  2018        PMID: 29905080     DOI: 10.1089/AID.2018.0102

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  Slow Receptor Binding of the Noncytopathic HIV-2UC1 Envs Is Balanced by Long-Lived Activation State and Efficient Fusion Activity.

Authors:  Miranda Harris; Sneha Ratnapriya; Angela Chov; Héctor Cervera; Alisha Block; Christopher Gu; Nathaniel Talledge; Louis M Mansky; Joseph Sodroski; Alon Herschhorn
Journal:  Cell Rep       Date:  2020-06-09       Impact factor: 9.423

2.  Regulation of epitope exposure in the gp41 membrane-proximal external region through interactions at the apex of HIV-1 Env.

Authors:  Hannah M Schapiro; Mukta D Khasnis; Koree Ahn; Alexandra Karagiaridi; Stephanie Hayden; Maria E Cilento; Michael J Root
Journal:  PLoS Pathog       Date:  2022-05-18       Impact factor: 7.464

3.  Myomedin scaffold variants targeted to 10E8 HIV-1 broadly neutralizing antibody mimic gp41 epitope and elicit HIV-1 virus-neutralizing sera in mice.

Authors:  Milan Kuchař; Petr Kosztyu; Veronika Daniel Lišková; Jiří Černý; Hana Petroková; Eliška Vróblová; Michal Malý; Lucie Vaňková; Michal Křupka; Leona Rašková Kafková; Pavlína Turánek Knotigová; Jarmila Dušková; Jan Dohnálek; Josef Mašek; Jaroslav Turánek; Milan Raška; Petr Malý
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

4.  Changes in the V1 Loop of HIV-1 Envelope Glycoproteins Can Allosterically Modulate the Trimer Association Domain and Reduce PGT145 Sensitivity.

Authors:  Héctor Cervera; Sneha Ratnapriya; Angela Chov; Alon Herschhorn
Journal:  ACS Infect Dis       Date:  2021-05-18       Impact factor: 5.578

5.  A Protocol for Studying HIV-1 Envelope Glycoprotein Function.

Authors:  Sneha Ratnapriya; Angela Chov; Alon Herschhorn
Journal:  STAR Protoc       Date:  2020-10-14

6.  A protocol for displaying viral envelope glycoproteins on the surface of vesicular stomatitis viruses.

Authors:  Touraj Aligholipour Farzani; Angela Chov; Alon Herschhorn
Journal:  STAR Protoc       Date:  2020-12-09

7.  Structure dynamics of HIV-1 Env trimers on native virions engaged with living T cells.

Authors:  Irene Carlon-Andres; Tomas Malinauskas; Sergi Padilla-Parra
Journal:  Commun Biol       Date:  2021-10-27

8.  Peptide Triazole Thiol Irreversibly Inactivates Metastable HIV-1 Env by Accessing Conformational Triggers Intrinsic to Virus-Cell Entry.

Authors:  Charles Gotuaco Ang; Erik Carter; Ann Haftl; Shiyu Zhang; Adel A Rashad; Michele Kutzler; Cameron F Abrams; Irwin M Chaiken
Journal:  Microorganisms       Date:  2021-06-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.